Recent developments in overcoming tumour cell multi-drug resistance

被引:15
作者
Ecker, G [1 ]
Chiba, P [1 ]
机构
[1] UNIV VIENNA,INST MED CHEM,A-1090 VIENNA,AUSTRIA
关键词
D O I
10.1517/13543776.7.6.589
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The development of unspecific mechanisms of resistance remains a serious impediment to cancer chemotherapy. The term multi-drug resistance (MDR) is defined as resistance of cancer cells to a broad variety of structurally and functionally diverse chemotherapeutic drugs. On the cellular level, several mechanisms responsible for MDR have been identified. In addition, numerous approaches for overcoming tumour cell MDR have been reported in the literature. This review focuses on patents published in 1995 and 1996 on modulators of MDR and related approaches to therapy of multi-drug resistant rumours.
引用
收藏
页码:589 / 599
页数:11
相关论文
共 104 条
[31]   RATIONAL DESIGN AND PRECLINICAL PHARMACOLOGY OF DRUGS FOR REVERSING MULTIDRUG RESISTANCE [J].
HAIT, WN ;
AFTAB, DT .
BIOCHEMICAL PHARMACOLOGY, 1992, 43 (01) :103-107
[32]  
HECKEL A, 1994, PHARM IU Z, V23, P177
[33]  
HYAFIL F, 1993, CANCER RES, V53, P4595
[34]   SURFACE GLYCOPROTEIN MODULATING DRUG PERMEABILITY IN CHINESE-HAMSTER OVARY CELL MUTANTS [J].
JULIANO, RL ;
LING, V .
BIOCHIMICA ET BIOPHYSICA ACTA, 1976, 455 (01) :152-162
[35]  
KANE SE, 1996, ADV DRUG RES, V28, P182
[36]  
KOBAYASHI H, 1994, CANCER RES, V54, P1271
[37]  
Kraus J.-L., 1995, Int. Patent, Patent No. [WO9512588, 9512588]
[38]   P53-DEPENDENT APOPTOSIS MODULATES THE CYTOTOXICITY OF ANTICANCER AGENTS [J].
LOWE, SW ;
RULEY, HE ;
JACKS, T ;
HOUSMAN, DE .
CELL, 1993, 74 (06) :957-967
[39]  
LUM BL, 1993, CANCER, V72, P3502, DOI 10.1002/1097-0142(19931201)72:11+<3502::AID-CNCR2820721618>3.0.CO
[40]  
2-N